课题基金 / 基金详情

REGULATION OF PROMER OF TGF-β/SMAD-TARGET GENE FOR ATTENUATION OF RENAL FIBROSIS

REGULATION OF PROMER OF TGF-β/SMAD-TARGET GENE FOR ATTENUATION OF RENAL FIBROSIS
TGF-β/SMAD 靶基因启动子的调节以减轻肾纤维化
批准号:
13671132
负责人:
TAMAKI Kiyoshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

TAMAKI Kiyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
TGF-β/Smad-target gene such as plasminogen activator inhibitor has Smad-binding element (SEE) in its promoter region. We generated artificial plasmid consisted of luciferase gene with SBE (SBE-Lux) in its promoter region. Using this plasmid, we have done experiments as follows. Cultured mesangial cells or smooth muscles cells was transfected with the plasmid and the cultured cells were treated with TGF-β or the substances, which are shown to induce the production of TGF-β. TGF-β increased the activity of SBE-Lux in dose-dependent manner. Angiotension II and Advanced glycation end product (AGE) also stimulated SBE-Lux activity. The activity was blocked by the presence of neutralizing anti-TGF-β antibody.Next, we generated artificial plasmid consisted of GFP (green fluorescence product) gene with SBE (SBE-GFP) in its promoter region. The cells transfected with the construct showed TGF-β-induced green color in its cytoplasma. Thus, the cell showing green fluolorescence was considered as TGF-β-target-cells. However, the cultured cells, which were transfected with the construct and treated with Angiotension II or AGE, have not shown green color enough to be identified. In addition, the tissues, which were transfectected with SBE-GFP, have not shown the green color induced by sclerotic damage. High concentration of TGF-β more than 10^<-2>ng/ml is necessary to induce the green fluolorescence in the transfected cells. Such high concentration of TGF-β was not considered to exist in the physiological or pathological condition. Thus, more sensitive artificial promoter is necessary to detect TGF-β activity.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
K.Tamaki et al.: "Role of TGF-β in the progression of renal fibrosis"Contribution to Nephrology. 139. 44-65 (2003)
K. Tamaki 等人:“TGF-β 在肾纤维化进展中的作用”肾病学贡献 139. 44-65 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamai O, Tamaki K,, Okuda S et al: "Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis."Kidney Int.. 59. 471-480 (2001)
Tamai O、Tamaki K、Okuda S 等人:“系膜细胞中的小窝和小窝蛋白在系膜增殖性肾小球肾炎中的表达。”Kidney Int.. 59. 471-480 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamaki K, Okuda S: "Role of TGF-β in the progression of renal fibrosis"Contribution to Nephrology. 139. 44-65 (2003)
Tamaki K、Okuda S:“TGF-β 在肾纤维化进展中的作用”肾病学贡献 139. 44-65 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Haramaki R, Tamaki K, et al.: "Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy"Am J Kidney Dis.. 38(6). 1191-1198 (2001)
Haramaki R、Tamaki K 等人:“IgA 肾病中的类固醇疗法和尿转化生长因子-β1”Am J Kidney Dis. 38(6)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Proteomic approach to protein involving diabetic nephropathy
    • 批准号:
      15590870
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      TAMAKI Kiyoshi
    • 依托单位:
    REGULATION OF TGF-β AND ITS SIGNAL MOLECULE, SMAD, FOR ATTENUATION OF GLOEMRULAR DISEASE.
    • 批准号:
      11671063
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      1999
    • 负责人:
      TAMAKI Kiyoshi
    • 依托单位:
    国内基金
    海外基金
    新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
    LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
    • 批准号:
      2026JJ82108
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭亮
    • 依托单位:
    基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
    独活寄生汤靶向调控TGF-β1/Smad信号通路介导间充质干细胞成软骨分化治疗KOA的作用机制研究
    • 批准号:
      2026JJ80282
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      段建辉
    • 依托单位: